Literature DB >> 12590163

Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y.

Jovana Gasic-Milenkovic1, Claudia Loske, Gerald Münch.   

Abstract

Advanced glycation endproducts (AGEs), sugar-derived protein modifications and lipid peroxidation products are prominent features of Alzheimer's disease. AGEs accumulate on beta-amyloid plaques during the course of the disease and can exert chronic oxidative stress via receptor-mediated mechanisms. Lipid peroxidation products such as hydroxynonenal, further markers of oxidative stress, are also increased in Alzheimer's diesease. In this study we present evidence for a direct biochemical link between AGEs and lipid peroxidation. Our results show that AGEs induce lipid peroxidation in a neuronal cell line in a dose-dependant manner, and that blocking the specific AGE-receptor RAGE, as well as using different antioxidants (alpha-lipoic acid, N-acetylcysteine, 17 beta-estradiol or aminoguanidine) can reduce the AGE-mediated formation of lipid peroxidation products. Thus, both RAGE antagonists and scavengers of oxygen free radicals could be useful in protecting brain tissue from lipid peroxidation and its pathophysilogical consequences that occur in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590163     DOI: 10.3233/jad-2003-5104

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

Review 1.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis.

Authors:  Fabricia Petronilho; Drielly Florentino; Lucinéia Gainski Danielski; Luiz Carlos Vieira; Maryane Modolon Martins; Andriele Vieira; Sandra Bonfante; Mariana Pereira Goldim; Francieli Vuolo
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

3.  Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells.

Authors:  Xu Wang; Song Yu; Chun-Yan Wang; Yue Wang; Hai-Xing Liu; Yong Cui; Li-De Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-08       Impact factor: 2.416

Review 4.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

Review 5.  Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.

Authors:  Matthew J Sharman; Giuseppe Verdile; Shanmugam Kirubakaran; Cristina Parenti; Ahilya Singh; Georgina Watt; Tim Karl; Dennis Chang; Chun Guang Li; Gerald Münch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 6.  Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?

Authors:  Michelli Erica Souza Ferreira; Amanda Soares de Vasconcelos; Thyago da Costa Vilhena; Thiago Leite da Silva; Aline da Silva Barbosa; Antonio Rafael Quadros Gomes; Maria Fani Dolabela; Sandro Percário
Journal:  Cell Mol Neurobiol       Date:  2015-01-24       Impact factor: 5.046

Review 7.  Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.

Authors:  Daniele Tibullo; Giovanni Li Volti; Cesarina Giallongo; Sonia Grasso; Daniele Tomassoni; Carmelina Daniela Anfuso; Gabriella Lupo; Francesco Amenta; Roberto Avola; Vincenzo Bramanti
Journal:  Inflamm Res       Date:  2017-07-04       Impact factor: 4.575

8.  Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.

Authors:  Sandra L Siedlak; Gemma Casadesus; Kate M Webber; Miguel A Pappolla; Craig S Atwood; Mark A Smith; George Perry
Journal:  Free Radic Res       Date:  2009-02

9.  The antioxidant 3H-1,2-dithiole-3-thione potentiates advanced glycation end-product-induced oxidative stress in SH-SY5Y cells.

Authors:  Robert Pazdro; John R Burgess
Journal:  Exp Diabetes Res       Date:  2012-05-17

10.  Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.

Authors:  Chiung-Huei Peng; Hsing-Chun Lin; Chih-Li Lin; Chau-Jong Wang; Chien-Ning Huang
Journal:  J Food Drug Anal       Date:  2018-08-14       Impact factor: 6.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.